Literature DB >> 32279332

Deficiency of 3-hydroxybutyrate dehydrogenase (BDH1) in mice causes low ketone body levels and fatty liver during fasting.

Hiroki Otsuka1,2, Takeshi Kimura1, Yasuhiko Ago1, Mina Nakama3, Yuka Aoyama1,4, Elsayed Abdelkreem1,5, Hideki Matsumoto1, Hidenori Ohnishi1, Hideo Sasai1,3, Masatake Osawa6,7, Seiji Yamaguchi8, Grant A Mitchell9, Toshiyuki Fukao1,3.   

Abstract

d-3-Hydroxy-n-butyrate dehydrogenase (BDH1; EC 1.1.1.30), encoded by BDH1, catalyzes the reversible reduction of acetoacetate (AcAc) to 3-hydroxybutyrate (3HB). BDH1 is the last enzyme of hepatic ketogenesis and the first enzyme of ketolysis. The hereditary deficiency of BDH1 has not yet been described in humans. To define the features of BDH1 deficiency in a mammalian model, we generated Bdh1-deficient mice (Bdh1 KO mice). Under normal housing conditions, with unrestricted access to food, Bdh1 KO mice showed normal growth, appearance, behavior, and fertility. In contrast, fasting produced marked differences from controls. Although Bdh1 KO mice survive fasting for at least 48 hours, blood 3HB levels remained very low in Bdh1 KO mice, and despite AcAc levels moderately higher than in controls, total ketone body levels in Bdh1 KO mice were significantly lower than in wild-type (WT) mice after 16, 24, and 48 hours fasting. Hepatic fat content at 24 hours of fasting was greater in Bdh1 KO than in WT mice. Systemic BDH1 deficiency was well tolerated under normal fed conditions but manifested during fasting with a marked increase in AcAc/3HB ratio and hepatic steatosis, indicating the importance of ketogenesis for lipid energy balance in the liver.
© 2020 SSIEM.

Entities:  

Keywords:  3-hydroxybutyrate dehydrogenase; CRISPR; fatty liver; ketone body; knockout mouse

Year:  2020        PMID: 32279332     DOI: 10.1002/jimd.12243

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  5 in total

1.  Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.

Authors:  Kota Yano; Kanji Yamaguchi; Yuya Seko; Shinya Okishio; Hiroshi Ishiba; Nozomi Tochiki; Aya Takahashi; Seita Kataoka; Keiichiroh Okuda; Yu Liu; Hideki Fujii; Atsushi Umemura; Michihisa Moriguchi; Takeshi Okanoue; Yoshito Itoh
Journal:  Lab Invest       Date:  2021-11-03       Impact factor: 5.662

2.  Metabolic and Signaling Roles of Ketone Bodies in Health and Disease.

Authors:  Patrycja Puchalska; Peter A Crawford
Journal:  Annu Rev Nutr       Date:  2021-10-11       Impact factor: 9.323

3.  Development and genetics of red coloration in the zebrafish relative Danio albolineatus.

Authors:  Delai Huang; Victor M Lewis; Tarah N Foster; Matthew B Toomey; Joseph C Corbo; David M Parichy
Journal:  Elife       Date:  2021-08-26       Impact factor: 8.140

4.  Anti-Tumor Effects of BDH1 in Acute Myeloid Leukemia.

Authors:  Fei Han; Huanhuan Zhao; Jun Lu; Weina Yun; Lingling Yang; Yude Lou; Dan Su; Xin Chen; Shixuan Zhang; Hanwei Jin; Xiang Li; Jie Sun; He Huang; Qishan Wang; Xi Jiang
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

5.  Bdh1 overexpression ameliorates hepatic injury by activation of Nrf2 in a MAFLD mouse model.

Authors:  Bu-Tuo Xu; Fang-Yuan Teng; Qi Wu; Sheng-Rong Wan; Xin-Yue Li; Xiao-Zhen Tan; Yong Xu; Zong-Zhe Jiang
Journal:  Cell Death Discov       Date:  2022-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.